' />
PMZ2123

Diabetic ketoacidosis

  • Gulati, A., Lavhale, M.S., Koenig, K., Havalad, S., 2009. ET receptor antagonist in the treatment of diabetic ketoacidosis (Abstract). J Clin Pharmacol 49:1125.
  • Gulati A., Lavhale M.S., Birinder S.M. and Havalad S., 2013. BQ123, an ETA receptor antagonist, in the treatment of diabetic ketoacidosis. To be presented at the 43rd Critical Care Congress January 9-13, 2014 San Francisco, California, USA
  • Gulati A., Lavhale M.S. and Havalad S. The involvement of endothelin in diabetic ketoacidosis. Poster presentation at: American Association of Pharmaceutical Scientists; 2009 November; Los Angeles, California.
  • Gulati A., Lavhale M.S., Koenig K and Havalad S. ET receptor antagonist in the treatment of diabetic ketoacidosis (DKA). Poster session presentation at the ET-11: American Physiological Society’s International Conference on Endothelin (2009 September), Montreal, Canada.
  • Gulati A., Lavhale M.S., Koenig K and Havalad S. ET receptor antagonist in the treatment of DKA. Poster session presentation at the 38th Annual meeting of American College of Clinical Pharmacology (2009 September), San Antonio, Texas.